APA (7th ed.) Citation

LY, M., M, K., E, T., DK, W., JH, M., TL, H., . . . MF, Y. (2019). Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients. Journal of gastroenterology and hepatology, 34(10), 1817. https://doi.org/10.1111/jgh.14637

Chicago Style (17th ed.) Citation

LY, Mak, et al. "Serum Mac-2-binding Protein Glycosylation Isomer and Risk of Hepatocellular Carcinoma in Entecavir-treated Chronic Hepatitis B Patients." Journal of Gastroenterology and Hepatology 34, no. 10 (2019): 1817. https://doi.org/10.1111/jgh.14637.

MLA (9th ed.) Citation

LY, Mak, et al. "Serum Mac-2-binding Protein Glycosylation Isomer and Risk of Hepatocellular Carcinoma in Entecavir-treated Chronic Hepatitis B Patients." Journal of Gastroenterology and Hepatology, vol. 34, no. 10, 2019, p. 1817, https://doi.org/10.1111/jgh.14637.